首页> 外文OA文献 >Probing the ligand binding domain of the GluR2 receptor by proteolysis and deletion mutagenesis defines domain boundaries and yields a crystallizable construct.
【2h】

Probing the ligand binding domain of the GluR2 receptor by proteolysis and deletion mutagenesis defines domain boundaries and yields a crystallizable construct.

机译:通过蛋白水解和缺失诱变探测GluR2受体的配体结合结构域定义了结构域边界并产生了可结晶的构建体。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ionotropic glutamate receptors constitute an important family of ligand-gated ion channels for which there is little biochemical or structural data. Here we probe the domain structure and boundaries of the ligand binding domain of the AMPA-sensitive GluR2 receptor by limited proteolysis and deletion mutagenesis. To identify the proteolytic fragments, Maldi mass spectrometry and N-terminal amino acid sequencing were employed. Trypsin digestion of HS1S2 (Chen GQ, Gouaux E. 1997. Proc Natl Acad Sci USA 94:13431-13436) in the presence and absence of glutamate showed that the ligand stabilized the S1 and S2 fragments against complete digestion. Using limited proteolysis and multiple sequence alignments of glutamate receptors as guides, nine constructs were made, folded, and screened for ligand binding activity. From this screen, the S1S21 construct proved to be trypsin- and chymotrypsin-resistant, stable to storage at 4 degrees C, and amenable to three-dimensional crystal formation. The HS1S21 variant was readily prepared on a large scale, the His tag was easily removed by trypsin, and crystals were produced that diffracted to beyond 1.5 A resolution. These experiments, for the first time, pave the way to economical overproduction of the ligand binding domains of glutamate receptors and more accurately map the boundaries of the ligand binding domain.
机译:离子型谷氨酸受体构成配体门控离子通道的重要家族,其生化或结构数据很少。在这里,我们通过有限的蛋白水解和缺失诱变来探测AMPA敏感GluR2受体的配体结合域的结构域和边界。为了鉴定蛋白水解片段,使用了Maldi质谱和N端氨基酸测序。在存在和不存在谷氨酸的情况下,HS1S2的胰蛋白酶消化(Chen GQ,Gouaux E. 1997. Proc Natl Acad Sci USA 94:13431-13436)表明,配体稳定了S1和S2片段以防止完全消化。使用有限的蛋白水解作用和谷氨酸受体的多序列比对作为指导,制备了九种构建体,折叠并筛选了配体结合活性。从该屏幕中,S1S21构建体被证明具有抗胰蛋白酶和胰凝乳蛋白酶的特性,在4摄氏度下可稳定储存,并易于形成三维晶体。 HS1S21变体很容易大规模制备,His标签很容易被胰蛋白酶去除,产生的晶体衍射到超过1.5 A的分辨率。这些实验首次为经济上过量生产谷氨酸受体的配体结合域铺平了道路,并更准确地绘制了配体结合域的边界。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号